TOMASSETTI, PAOLA
 Distribuzione geografica
Continente #
NA - Nord America 6.324
AS - Asia 4.917
EU - Europa 4.068
SA - Sud America 319
AF - Africa 261
Continente sconosciuto - Info sul continente non disponibili 169
OC - Oceania 2
Totale 16.060
Nazione #
US - Stati Uniti d'America 6.255
VN - Vietnam 1.568
CN - Cina 1.271
GB - Regno Unito 1.254
SG - Singapore 1.224
DE - Germania 542
IT - Italia 427
SE - Svezia 416
UA - Ucraina 379
FR - Francia 303
HK - Hong Kong 262
RU - Federazione Russa 237
BR - Brasile 230
IN - India 225
IE - Irlanda 134
JP - Giappone 90
ZA - Sudafrica 87
EE - Estonia 85
CH - Svizzera 81
BD - Bangladesh 78
FI - Finlandia 70
TG - Togo 60
AR - Argentina 42
CI - Costa d'Avorio 42
KR - Corea 42
NL - Olanda 41
CA - Canada 29
SC - Seychelles 28
NG - Nigeria 24
BE - Belgio 22
TH - Thailandia 19
MX - Messico 18
JO - Giordania 17
EC - Ecuador 16
PL - Polonia 16
PH - Filippine 15
TW - Taiwan 15
UZ - Uzbekistan 15
AT - Austria 14
TR - Turchia 13
IQ - Iraq 11
BG - Bulgaria 10
GR - Grecia 10
CL - Cile 8
PK - Pakistan 8
ID - Indonesia 7
PY - Paraguay 7
SA - Arabia Saudita 7
IR - Iran 6
LB - Libano 6
CO - Colombia 5
EG - Egitto 5
MA - Marocco 5
MY - Malesia 5
PE - Perù 5
RO - Romania 5
ES - Italia 4
LT - Lituania 4
TN - Tunisia 4
TT - Trinidad e Tobago 4
UY - Uruguay 4
CZ - Repubblica Ceca 3
GT - Guatemala 3
HR - Croazia 3
HU - Ungheria 3
JM - Giamaica 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AU - Australia 2
AZ - Azerbaigian 2
CR - Costa Rica 2
ET - Etiopia 2
HN - Honduras 2
NP - Nepal 2
PR - Porto Rico 2
SV - El Salvador 2
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BS - Bahamas 1
CG - Congo 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EU - Europa 1
GH - Ghana 1
GY - Guiana 1
IL - Israele 1
KE - Kenya 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
LY - Libia 1
MD - Moldavia 1
NI - Nicaragua 1
PT - Portogallo 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
VE - Venezuela 1
VI - Stati Uniti Isole Vergini 1
Totale 15.894
Città #
Southend 1.126
Singapore 809
Fairfield 618
Ashburn 545
Chandler 389
Ho Chi Minh City 317
San Jose 312
Seattle 295
Woodbridge 291
Wilmington 281
Hanoi 273
Jacksonville 267
Dong Ket 258
Hong Kong 257
Houston 257
Santa Clara 257
Cambridge 229
Princeton 224
Ann Arbor 180
Council Bluffs 163
Beijing 158
Hefei 141
Boardman 135
Dublin 134
Lauterbourg 120
Padova 105
Westminster 103
Nanjing 102
Los Angeles 85
Tokyo 82
Berlin 79
Bern 74
Helsinki 70
Milan 62
Lomé 60
Da Nang 53
Shenyang 53
Nanchang 50
Saint Petersburg 49
New York 48
Mülheim 47
Bologna 46
Dallas 46
Jinan 46
Abidjan 42
San Diego 40
Haiphong 39
Medford 36
Seoul 35
Buffalo 34
Changsha 34
Tianjin 34
São Paulo 33
Guangzhou 30
Shanghai 28
Hebei 27
Redondo Beach 26
Des Moines 25
Abeokuta 24
Mahé 24
Frankfurt am Main 22
Phoenix 19
Biên Hòa 18
Fuzhou 18
Jiaxing 18
Wuhan 18
Amman 17
Ningbo 17
Brussels 16
Turin 16
Washington 16
Bremen 15
Hải Dương 15
Norwalk 15
Yubileyny 15
Bengaluru 14
Hangzhou 14
Zhengzhou 14
Verona 13
Ha Long 12
Haikou 12
Paris 12
Rome 12
Shijiazhuang 12
Dearborn 11
North Charleston 11
Can Tho 10
Chicago 10
Falkenstein 10
London 10
Olalla 10
Quận Bình Thạnh 10
San Francisco 10
Sofia 10
Atlanta 9
Florence 9
Ninh Bình 9
Taizhou 9
Vienna 9
Vinh 9
Totale 10.333
Nome #
Thymic neuroendocrine carcinoma (carcinoid) in multiple endocrine neoplasia type 1 syndrome: the Italian series. 329
Basis for treatment of functioning neuroendocrine tumours. 237
Four cases of carcinoid tumour in Crohn's disease: coincidence or correlation? 229
Chromogranin A: is it a useful marker of neuroendocrine tumors? 229
(68)Ga-DOTA-NOC PET/CT in comparison with CT for the detection of bone metastasis in patients with neuroendocrine tumours. 227
Contrast-enhanced ultrasound in the differential diagnosis of exocrine versus neuroendocrine pancreatic tumors 226
Adult coeliac disease diagnosed by endoscopic biopsies in the duodenal bulb. 224
Endocrine pancreatic tumors: factors correlated with survival. 222
A case of primary pancreatic lymphoma. 219
WHO 2010 classification of pancreatic endocrine tumors. Is the new always better than the old? 214
The ELISA fecal elastase-1 polyclonal assay reacts with different antigens than those of the monoclonal assay. 211
68Ga-DOTANOC PET/CT Clinical Impact in Patients with Neuroendocrine Tumors. 205
Exocrine pancreatic function after alcoholic or biliary acute pancreatitis 204
Risk factors of type 1 gastric neuroendocrine neoplasia in patients with chronic atrophic gastritis. A retrospective, multicentre study 199
68Ga-labelled peptides for diagnosis of gastroenteropancreatic NET. 199
Are There Prognostic Factors Related to Recurrence in Pancreatic Endocrine tumors? 197
Acute leukaemia following low dose peptide receptor radionuclide therapy for an intestinal carcinoid. 195
Comparison between (68)Ga-DOTA-NOC and (18)F-DOPA PET for the detection of gastro-entero-pancreatic and lung neuro-endocrine tumours. 192
Endocrine tumors of the ileum: factors correlated with survival. 190
Clinical management of patients with gastric neuroendocrine neoplasms associated with chronic atrophic gastritis: a retrospective, multicentre study 189
The role of lymph node ratio in recurrence after curative surgery for pancreatic endocrine tumours. 189
Il percorso diagnostico preoperatorio e la preparazione all'intervento chirurgico 185
Advanced digestive neuroendocrine tumors: metastatic pattern is an independent factor affecting clinical outcome. 185
Rapid and sustained relief from the symptoms of carcinoid syndrome: results from an open 6-month study of the 28-day prolonged-release formulation of lanreotide. 181
Zollinger-Ellison syndrome. Diagnosis and therapy. 180
Capsule endoscopy for the diagnosis of midgut neuroendocrine carcinoma. 180
Medical treatment of endocrine gastroenteropancreatic tumors. 177
Water-related techniques in colonoscopy: the end justifies the means! 175
Clinical approach to diarrhea 174
Evaluation of unusual neuroendocrine tumours by means of (68)Ga-DOTA-NOC PET. 172
Plasma acylated ghrelin levels are higher in patients with chronic atrophic gastritis. 172
Sedation during colonoscopy and the benefits of lubrication 165
Pancreatic endocrine tumors less than 4 cm in diameter: resect or enucleate? a single-center experience. 162
Validation of the 2010 WHO classification and a new prognostic proposal: A single centre retrospective study of well-differentiated pancreatic neuroendocrine tumours 162
Patient-reported outcomes in patients with endocrine tumors of the Ileum 160
Management of patients with gastrointestinal stromal tumor in clinical practice in Italy: a critical "event tree model" analysis of decision-making processes and outcomes. 160
Lubrication during colonoscopy: a forgotten factor. 159
Routine duodenal biopsies: is it time to change our minds? 157
Standardized uptake values of (68)Ga-DOTANOC PET: a promising prognostic tool in neuroendocrine tumors. 157
Everolimus for advanced pancreatic neuroendocrine tumors. 157
Ipotesi di percorso diagnostico terapeutico dei tumori del pancreas. 154
Radiolabelled somatostatin analogue treatment in gastroenteropancreatic neuroendocrine tumours: factors associated with response and suggestions for therapeutic sequence. 154
Characterization of neuroendocrine pancreatic cancer with multidetector computer tomography and magneti resonance. 153
Gastric endocrine tumors type I: treatment with long-acting somatostatin analogs 153
Warm water and oil assistance in colonoscopy 152
Long-term survival in neuroendocrine tumors of the pancreas. 151
Patient-reported outcomes in subjects with neuroendocrine tumors of the pancreas. 149
Neuroendocrine tumor of the pancreas and GIST: is there a correlation? 148
WHO-2010 and WHO-2000 classifications for pancreatic endocrine tumors. Is it time to change ? 148
Multiple gastric endocrine tumors and gastrinomas of the duodenum in a patient with a ZES MEN I 147
Clinicopathological features of pancreatic endocrine tumors: a prospective multicenter study in Italy of 297 sporadic cases 147
CRITICAL ANALYSIS ON MANAGEMENT OF GIST PATIENTS WITH EVENT TREE MODEL 147
Warm water and oil for the difficult colon 147
Oil-lubricated colonoscopy: easier and less painful? 146
Warm water or oil-assisted colonoscopy: toward simpler examinations? 146
Maffucci syndrome with hemangioma of the liver 146
Chromogranin A as a marker of neuroendocrine neoplasia: an Italian Multicenter Study. 145
Treatment of Zollinger-Ellison Syndrome 145
Sedation on demand and lubrication during colonoscopy: should we change our mind ? 144
Comparison between two methods in the determination of circulating chromogranin A in neuroendocrine tumors (NETs): results of a prospective multicenter observational study. 143
Neuroendocrine tumor of the pancreas and GIST: is there a correlation ? 143
Quality of life in chronic pancreatitis. 140
The surgical treatment of neuroendocrine pancreatoduodenal tumors in multiple endocrine neoplasia type 1 140
Benign pancreatic hyperenzymemia: Lights on a clinical challenge 140
Lymph Node Ratio as a Prognostic Factor in Patients with Pancreatic Endocrine Tumours JOP 139
Is 68Ga-DOTA-NOC PET/CT indicated in patients with clinical, biochemical or radiological suspicion of neuroendocrine tumour? 139
Value of both WHO and TNM classification systems for patients with pancreatic endocrine tumors: results of a single-center series. 137
Characterization of neuroendocrine pancreatic cancer with multidetector computed tomography and magnetic resonance. 135
ENETS Consensus Guidelines for the Management of Patients with Gastroduodenal Neoplasms. 133
Real-world study of everolimus in advanced progressive neuroendocrine tumors. 133
Echo-enhanced ultrasonography: is it the future gold standard of imaging in acute pancreatitis? 132
Role of 18F-dopa PET/CT imaging in the management of patients with 111In-pentetreotide negative GEP tumours. 131
Management of acute pancreatitis: current knowledge and future perspectives. 127
Final results of a phase 2A study for the treatment of metastatic neuroendocrine tumors with a fixed activity of (90) Y-DOTA-D-Phe1-Tyr3 octreotide. 127
68Ga-DOTA-NOC and 18F-DOPA PET in the evaluation of patients with neuroendocrine tumours. 126
Radiolabelled somatostatin analogue treatment in gastroenteropancreatic neuroendocrine tumours: factors associated with response and suggestions for therapeutic sequence: response to comments by Ezziddin et al. 126
Neuroendocrine Tumours with Secondary Liver Lesions 124
Risk and Protective Factors for Small Intestine Neuroendocrine Tumours: A Prospective Case-Control Study 124
The search of the stool and blood K-ras mutations in patients with pancreatic mass. 122
Warm water or oil-assisted colonoscopy: toward simpler examination ? 122
Surgical treatment of non-functioning pancreatic islet cell tumors 121
Neoplasie endocrine del pancreas: follow-up clinico e terapeutico. In Attualità in pancreatologia. 121
PET/CT with 68Gallium-DOTA-peptides in NET: an overview. 121
Factors related to long-term survival in patients affected by well-differentiated endocrine tumors of the pancreas. ISRN Surg. 389385. [IF: 2.000] 121
Metastatic and locally advanced pancreatic endocrine carcinomas: analysis of factors associated with disease progression. 120
WHO 2010 and WHO 2000 Classification: From a Sensitive Analysis to Reality 117
null 117
Medical Therapy of Malabsorption in Patients with Head Pancreatic Resection 116
Contrast-enhanced ultrasound in the differential diagnosis between esocrine and endocrine solid tumors of the pancreas. 115
PATINUM-BASED CHEMOTHERAPY FOR THE TREATMENT OF HIGH-GRADE GASTROINTESTINAL AND UNKNOWN PRIMARY NEUROENDOCRINE NEOPLASMS 112
Are there prognostics factors related to recurrence in neuroendocrine pancreatic tumors ? 109
Functional imaging of digestive endocrine tumors. 108
Prognostic value of 68Ga-DOTA-NOC PET/CT SUVmax in patients with neuroendocrine tumours of the pancreas 108
Risk Factors for Disease Progression in Advanced Jejunoileal Neuroendocrine Tumors. 107
Oil-lubricated colonoscopy: a new technique for easier examination? 100
Neoplasie endocrine del pancreas: follow-up clinico e terapeutico. 99
Somatostatin analogues: The state of the art. 98
The search of the stool and blood K-ras mutations in patients with pancreatic mass. A prospective study. 91
Surgical treatment of non-functioning islet cell tumors. 91
The surgical treatment of neuroendocrine pancreatoduodenal tumors in multiple endocrine neoplasia type 1 91
Totale 15.534
Categoria #
all - tutte 44.960
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.960


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.661 0 67 115 159 149 100 35 114 50 74 501 297
2022/20231.874 195 285 91 224 148 129 43 75 317 58 162 147
2023/2024439 40 89 41 47 51 74 21 16 17 18 7 18
2024/20251.782 38 351 165 111 433 87 130 40 6 84 11 326
2025/20264.320 424 439 410 291 497 230 369 215 778 322 149 196
2026/2027290 108 182 0 0 0 0 0 0 0 0 0 0
Totale 16.060